Have a personal or library account? Click to login
Genotoxicity of aluminium oxide, iron oxide, and copper nanoparticles in mouse bone marrow cells Cover

Genotoxicity of aluminium oxide, iron oxide, and copper nanoparticles in mouse bone marrow cells

Open Access
|Dec 2021

Figures & Tables

Figure 1

Reticulocyte micronucleus frequency (%MN-RETs) in mice treated with Fe2O3 or Al2O3 nanoparticles and a single dose of mitomycin C (MMC). * significant difference (P<0.05) from negative control (0)
Reticulocyte micronucleus frequency (%MN-RETs) in mice treated with Fe2O3 or Al2O3 nanoparticles and a single dose of mitomycin C (MMC). * significant difference (P<0.05) from negative control (0)

Figure 2

Reticulocyte micronucleus frequency (%MN-RETs) in mice treated with Cu nanoparticles and a single dose of mitomycin C (MMC). * significant difference (P<0.05) from negative control (0)
Reticulocyte micronucleus frequency (%MN-RETs) in mice treated with Cu nanoparticles and a single dose of mitomycin C (MMC). * significant difference (P<0.05) from negative control (0)

Figure 3

Reticulocyte frequency (%RETs) in mice treated with Fe2O3 or Al2O3 nanoparticles and a single dose of mitomycin C (MMC). *significant difference (P<0.05) from negative control (0)
Reticulocyte frequency (%RETs) in mice treated with Fe2O3 or Al2O3 nanoparticles and a single dose of mitomycin C (MMC). *significant difference (P<0.05) from negative control (0)

Figure 4

Reticulocyte frequency (%RET) in mice treated with Cu nanoparticles and a single dose of mitomycin C (MMC). *significant difference (P<0.05) from negative control (0)
Reticulocyte frequency (%RET) in mice treated with Cu nanoparticles and a single dose of mitomycin C (MMC). *significant difference (P<0.05) from negative control (0)

Figure 5

DNA damage induced by Al2O3 nanoparticles in mice bone marrow measured by the standard and enzyme-modified comet assays. * significant difference (P<0.05) from negative control. EndoIII – endonuclease III-modified comet assay; hOGG1 – human 8-hydroxyguanine DNA-glycosylase-modified comet assay; MMS – methyl methanesulphonate. Note: the reason for low hOGG1 findings with MMS is that it cannot detect alkylating damage caused by it (43)
DNA damage induced by Al2O3 nanoparticles in mice bone marrow measured by the standard and enzyme-modified comet assays. * significant difference (P<0.05) from negative control. EndoIII – endonuclease III-modified comet assay; hOGG1 – human 8-hydroxyguanine DNA-glycosylase-modified comet assay; MMS – methyl methanesulphonate. Note: the reason for low hOGG1 findings with MMS is that it cannot detect alkylating damage caused by it (43)

Figure 6

DNA damage induced by Fe2O3 nanoparticles in mice bone marrow measured by the standard and enzyme-modified comet assays. * significant difference (P<0.05) from negative control. EndoIII – endonuclease III-modified comet assay; hOGG1 – human 8-hydroxyguanine DNA-glycosylase-modified comet assay; MMS – methyl methanesulphonate. Note: the reason for low hOGG1 findings with MMS is that it cannot detect alkylating damage caused by it (43)
DNA damage induced by Fe2O3 nanoparticles in mice bone marrow measured by the standard and enzyme-modified comet assays. * significant difference (P<0.05) from negative control. EndoIII – endonuclease III-modified comet assay; hOGG1 – human 8-hydroxyguanine DNA-glycosylase-modified comet assay; MMS – methyl methanesulphonate. Note: the reason for low hOGG1 findings with MMS is that it cannot detect alkylating damage caused by it (43)

Figure 7

DNA damage induced by Cu nanoparticles in mice bone marrow measured by the standard and enzyme-modified comet assays. * significant difference (P<0.05) from negative control. EndoIII – endonuclease III-modified comet assay; hOGG1 – human 8-hydroxyguanine DNA-glycosylase-modified comet assay; MMS – methyl methanesulphonate. Note: the reason for low hOGG1 findings with MMS is that it cannot detect alkylating damage caused by it (43)
DNA damage induced by Cu nanoparticles in mice bone marrow measured by the standard and enzyme-modified comet assays. * significant difference (P<0.05) from negative control. EndoIII – endonuclease III-modified comet assay; hOGG1 – human 8-hydroxyguanine DNA-glycosylase-modified comet assay; MMS – methyl methanesulphonate. Note: the reason for low hOGG1 findings with MMS is that it cannot detect alkylating damage caused by it (43)

Chromosomal aberrations in bone marrow cells of male BALB/c mice treated with Fe2O3, Al2O3 and Cu nanoparticles

GroupDose (mg/kg)No. of analysed metaphasesChromosomal aberrationsTA/500 cellsCA/cell Mean ± SD
CtBChBCtGChG
Fe2O3 nanoparticles
NC050018131415600.120±0.026
PC250010635104603050.610±0.081*
17550021103515890.178±0.057
215050020123810860.172±0.023
330050027094016920.184±0.029
Al2O3 nanoparticles
NC050014161117580.116±0.019
PC250010241115533110.622±0.147*
17550020133812830.166±0.081
215050015104310790.158±0.046
330050019144011890.168±0.039
Cu nanoparticles
NC050015121816610.12 ±0.037
PC25009835110613040.608±0.081*
1550020132215700.140±0.054
21050019142016690.138±0.048
315500502668411850.370±0.076*

The experimental design for the genotoxicity assessment of Al2O3, Fe2O3, and Cu nanoparticles using male BALB/c mice

NanoparticlesGenotoxicity assayNo of animalsGroupsDose (mg/kg)
Al2A3Chromosomal aberration15=3 per groupNC0
175
2150
3300
MMC (PC)2
Micronucleus assay15=3 per groupNC0
175
2150
3300
MMC (PC)2
Comet assay15=3 per groupNC0
175
2150
3300
MMS (PC)100
Fe2O3Chromosomal aberration15=3 per groupNC0
175
2150
3300
MMC (PC)2
Micronucleus assay15=3 per groupNC0
175
2150
3300
MMC (PC)2
Comet assay15=3 per groupNC0
175
2150
3300
MMS (PC)100
CuChromosomal aberration15=3 per groupNC0
15
210
315
MMC (PC)2
Micronucleus assay15=3 per groupNC0
15
210
315
MMC (PC)2
Comet assay15=3 per groupNC0
15
210
315
MMS (PC)100

Mitotic index in bone marrow cells of male BALB/c mice treated with Fe2O3, Al2O3, and Cu nanoparticles

GroupDose (mg/kg)No. of analysed metaphasesNo. of mitotic cellsMitotic index (%)
Fe2O3 nanoparticles
NC050004098.180±0.540
PC25000611.220±0.259*
17550003997.980±0.370
215050003957.900±0.709
330050004018.080±1.180
Al2O3 nanoparticles
NC050004178.340±0.351
PC25000581.160±0.288*
17550004038.060±0.517
215050004098.180±0.687
330050003997.980±0.991
Cu nanoparticles
NC050004118.220±0.277
PC25000541.080±0.238*
1550004068.120±0.868
21050003997.980±0.673
31550003096.180±0.802*
DOI: https://doi.org/10.2478/aiht-2021-72-3578 | Journal eISSN: 1848-6312 | Journal ISSN: 0004-1254
Language: English, Croatian, Slovenian
Page range: 315 - 325
Submitted on: Jul 1, 2021
Accepted on: Nov 1, 2021
Published on: Dec 30, 2021
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Rakhshinda Sadiq, Qaiser Mahmood Khan, Ameena Mobeen, Asma Shah, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.